A carregar...
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...
Na minha lista:
| Publicado no: | Brain Behav |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/ https://ncbi.nlm.nih.gov/pubmed/28948074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|